Aus grants US$18m for radiation oncology unit in NT
This article was originally published in Clinica
Executive Summary
Funding for a new radiation oncology unit to be set up on the Royal Darwin Hospital site to serve Australia’s Northern Territory has been granted. The provider of the Darwin-based service is to be the Royal Adelaide Hospital (RAH), which will be responsible for ordering the linear accelerator machines and other specialised equipment for the facility, which will have an initial capacity to treat 400 patients per year. The total investment by the federal government into the unit is Aus$19m (US$18m); the availability of Aus$5.7m of the total amount, to commence work on the unit, was confirmed in June 2008. Construction of the site began on July 18. The agreement with the RAH will be finalised in August and will be to provide the service for 10 years.
You may also be interested in...
Asia Regulatory Forum Update
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia adopts interim device authorisation regulation
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
Canada takes action to increase more adverse event reporting
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.